PGY2 Program
Residency Program Director
-
Tracy Wiczer, PharmD, BCOP
- PGY2 Oncology Residency Program Director, The James Cancer Hospital at The Ohio State University
- PGY2 Oncology, The James Cancer Hospital at The Ohio State University
- PGY1, The Jewish Hospital-Mercy Health, Cincinnati, Ohio
- PharmD, University of Cinicinnati
Previous Year Residents
-
Victoria Yosick, PharmD
Inpatient/Outpatient Lymphoma & Myeloma Pharmacy Float, The James OSUWMC -
Nicole Gula, PharmD
Inpatient Hematology/Oncology Pharmacy Specialist, The James OSUWMC -
Adithya Ghantae, PharmD
Outpatient Clinical Oncology Pharmacist, Novant Health, Mooresville, NC -
Kennedi Satterfield, PharmD
Bone Marrow Transplant Clinical Specialist Pharmacist, The James OSUWMC -
Delvin Omer, PharmD
Outpatient Lymphoma/Inpatient Hematology Clinical Pharmacy Specialist, Atrium Health Wake Forest Baptist Medical Center, Winston Salem, NC -
Nilmarie Ayala Fontanez, PharmD, MS
Inpatient/Outpatient Hematology/Oncology Float Specialist-The James OSUWMC -
Nathan Lamb, PharmD, BCPS
Clinical Pharmacy Specialist-BMT/Cellular Therapy-Moffitt Cancer Center-Tampa, FL -
Courtney Krall, PharmD, MPH
Outpatient Hematology/Oncology Clinical Pharmacy Specialist-The James OSUWMC -
Zachary Arnold, PharmD
Hematology/Oncology Specialty Practice Pharmacy Float-The James OSUWMC -
Jasmine Browning, PharmD
Hematology/Oncology Clinical Pharmacist, University of Louisville Hospital Brown Cancer Center -
Tyler Smith, PharmD
Hematology/Oncology Pharmacist Specialist at The James Cancer Hospital -
TJ Schieber, PharmD, MBA
Clinical Oncology Pharmacist - The University of Kansas Health System -
Riley Karpen, PharmD, MBA
Clinical Oncology Pharmacist - The University of Kansas Health System -
Anna Clennon, PharmD
Clinical Pharmacy Oncology/Hematology Specialist at Froedtert Hospital and the Medical College of Wisconsin -
Shivani Prakshesh Patel, PharmD
Clinical Pharmacist Specialist, University of Chicago Medicine -
Samantha Musson, PharmD
Hematology/Oncology Pharmacist Specialist at Christ Hospital in Cincinnati, Ohio -
Lexus Frazier, PharmD
Hematology/Oncology Pharmacist Specialist at The James Cancer Hospital -
Megan Fleming, PharmD
Hematology/Oncology Pharmacist Specialist, The James Cancer Hospital -
LeeAnn Geraghty, PharmD
Clinical Hematology/Oncology Specialist Pharmacist, Norton Healthcare, Louisville, KY
About the PGY2 Oncology Residency Program
Residency Sites
The OSUCCC – James strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care — a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of 51 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs sponsored by the NCI. As the cancer program’s 356-bed adult patient-care component, The James is one of the top
cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet® designation, the highest honor an organization can receive for quality patient care and professional nursing practice. With 21 floors and more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care.
Read More
The center includes six outpatient chemotherapy infusion clinics, dispensing an estimate of over 75,000 doses of chemotherapy annually. The Department of Pharmacy consists of inpatient and outpatient hematology/oncology clinical
specialist pharmacists, pain and palliative medicine pharmacists, anti-coagulation pharmacists, cancer informatics pharmacists, medication assistance pharmacists, and Hematology/Oncology specialty practice pharmacy residents.
The James Cancer Hospital at The Ohio State University offers a one-year postgraduate year two (PGY2) ASHP accredited oncology pharmacy residency program. The clinical pharmacy program is designed to align with our subspecialized disease specific model allowing residents the opportunity to train with clinical specialists who are experts in their subspecialty in both inpatient and ambulatory clinic setting. The program allows residents to develop their hematology/oncology knowledge base including cancer treatment, supportive care, and the role of clinical trials in this patient population. Upon completion of the program, the resident will have the skillset necessary to work as a respected member of a multi-disciplinary hematology/oncology patient care team.
KEY ROTATIONS/EXPERIENCES
The resident will complete a combination of rotations and longitudinal experiences designed around the core objectives specified by ASHP in addition to the resident’s interest.
Orientation: 4 weeks (orientation may be modified for early commit residents)
Research: 3-4 weeks
Hematology
- Inpatient Acute Leukemia – 4 weeks
- Bone Marrow Transplantation – 4 weeks
- Inpatient Lymphoma – 4 weeks
- Outpatient Hematology Clinics (Chronic Leukemias, Multiple Myeloma, & lymphoma)
Oncology
- Inpatient Oncology – 4 weeks
- Outpatient Solid Tumor Clinics
- Outpatient Breast Cancer – 3 weeks
- Outpatient Gastrointestinal Cancers (GI) + Melanoma – 4 weeks
- Outpatient Lung (thoracic)/Gynecology Oncology (Gyn Onc) – 3 weeks
- Outpatient Genitourinary (GU) – 3 weeks
Clinical trials unit (CTU): 1 week
Pain and Palliative: 2 weeks
Administration: 1 week
- Required Longitudinal
- Medication Assistance
- Medication Safety
- Teaching
- Research/MUE
Electives: 4-8 weeks, experiences can be 1-4 weeks in length, electives not listed below can be arranged on specific request
- Anything in required repeated
- Inpatient Leukemia/Transplant
- Inpatient CLL/MM/Misc. Heme
- Inpatient Benign Heme
- Inpatient Gynecology
- Outpatient Leukemia/BMT
- Outpatient Head & Neck
- Outpatient Sarcoma
- Outpatient Melanoma
- Outpatient Gynecology Oncology
- Outpatient Neuro-oncology
- Oncology Administration
- Informatics
- Infectious Diseases
- Pediatric Hematology/Oncology (Nationwide Children’s Hospital)
Key Preceptors
Learn more about the Hematology/Oncology key preceptors:
Read MoreINPATIENT/OUTPATIENT HEMATOLOGY
- Rebecca Evers, PharmD, BCOP
Outpatient Multiple Myeloma and Lymphoma - Pooja Kumar, PharmD, BCOP
Inpatient/Outpatient BMT and Acute Leukemia - Jaelyn Westfield, PharmD, BCOP
Outpatient Multiple Myeloma and Lymphoma - Taylor Gabbard, PharmD, BCOP
Inpatient Multiple Myeloma - Tracelyn Freeman, PharmD, BCOP
Inpatient/Outpatient BMT and Acute Leukemia - Megan Fleming, PharmD, BCOP
Inpatient/Outpatient BMT and Acute Leukemia - Jeremy Sen, PharmD, BCOP
Inpatient/Outpatient BMT and Acute Leukemia - Tyler Everhardt, PharmD, BCOP
Inpatient/Outpatient Benign Hematology, Chronic Lymphocytic Leukemia, and Lymphoma - Justin Tossey, PharmD, BCOP
Inpatient/Outpatient BMT and Acute Leukemia - Ally Waller, PharmD, BCOP
Inpatient/Outpatient BMT and Acute Leukemia - Lexus Frazier, PharmD, BCOP
Inpatient/Outpatient BMT and Acute Leukemia - Caitlyn Crawford, PharmD, BCOP
Inpatient/Outpatient Benign Hematology, Chronic Lymphocytic Leukemia, and Lymphoma - Lindsay Rosen, PharmD, BCOP
Inpatient/Outpatient Benign Hematology, Chronic Lymphocytic Leukemia, and Lymphoma - Jordan Lundberg, PharmD, BCOP
Inpatient/Outpatient Benign Hematology, Chronic Lymphocytic Leukemia, and Lymphoma - Tracy Wiczer, PharmD, BCOP
Inpatient/Outpatient Benign Hematology, Chronic Lymphocytic Leukemia, and Lymphoma
INPATIENT/OUTPATIENT ONCOLOGY
- Matt Arango, PharmD, BCOP
Outpatient Gastrointestinal Cancer - Caleb Good, PharmD
Inpatient Medical Oncology/Outpatient Melanoma & Neuroendocrine - Brianna Archambeau, PharmD, BCOP
Inpatient Medical Oncology - Hunter Patton, PharmD, BCPS
Inpatient Medical Oncology - Molly Russell, PharmD
Inpatient Medical Oncology/Outpatient Head & Neck Cancer - Andrew Stone, PharmD, BCPS
Inpatient Medical Oncology - Michael Berger, PharmD, BCOP
Outpatient Breast Cancer - Stephanie Collins, PharmD, BCOP
Outpatient Breast Cancer - Eric Fela, PharmD, BCOP
Outpatient Gynecologic Cancers - Ambar Khan, PharmD, BCOP
Outpatient Gynecologic Cancers - Megan Hinkley, PharmD, BCOP
Outpatient Genitourinary Cancers, Lung Cancer - Sarah Hoffman, PharmD, BCOP
Outpatient Sarcoma - Gretchen Pardo, PharmD, BCOP
Inpatient Medical Oncology/Outpatient Head & Neck Cancer - Hiba Alzouby, PharmD
Outpatient Gastrointestinal Oncology - Kristen Nymberg, PharmD, BCOP
Outpatient Genitourinary - Tommy Montgomery, PharmD, BCOP
Inpatient Medical Oncology - Allison Reed, PharmD, BCPS, BCOP
Outpatient Breast Center - Lauren Ledbetter, PharmD, BCOP
Outpatient Lung Cancer - Michael Smith, PharmD, BCOP
Outpatient Lung Cancer & Neuro-oncology
HEMATOLOGY/ONCOLOGY FLOATS
- Connor Aossey, PharmD
Hematology/Oncology Float - Tyler Dickerson, PharmD, BCOP
Hematology/Oncology Float - Natalia Hartzler, PharmD, BCOP
Hematology/Oncology Float - Tyler Smith, PharmD, BCOP
Hematology/Oncology Float
HEMATOLOGY/ONCOLOGY ANTICOAGULATION
- Paige Erdeljac, PharmD, BCACP
Hematology/Oncology Anticoagulation - Stephanie Yager, PharmD, BCACP
Hematology/Oncology Anticoagulation
PAIN AND PALLIATIVE MEDICINE
- Jessica Hirsch, PharmD
Palliative Medicine - Gary Houchard, PharmD
Palliative Medicine - Justin Kullgren, PharmD, CPE
Palliative Medicine - Maureen Saphire, PharmD, BCGP, CDP
Palliative Medicine
OTHER HEMATOLOGY AND ONCOLOGY PRECEPTORS
- Amber Hartman, PharmD
Medication Safety - Naomi Digiantonio, PharmD, BCPS
Generalist Pharmacist, Clinical Trials Unit - Justin Osorio, PharmD, BCPS
Generalist Pharmacist, Inpatient Benign Hematology - Jacquelyn Williams, PharmD
Generalist Pharmacist, Inpatient Benign Hematology
ADMINISTRATION
- Amanda Sabol, PharmD, MS, BCPS
Assistant Director, Investigational Drug Service - Janinah Barreto, PharmD, MS, CPHIMS
Assistant Director, Pharmacy Informatics Clinical Applications - Mitch Dorn, PharmD, MS
Associate Director, Central Pharmacies - Morgan Forshay, PharmD, MS, BCPS
Pharmacy Manager, Inpatient Oncology - Sarah Hudson-Disalle, PharmD
Pharmacy Manager, Prior Authorization - Julie Kennerly-Shah, PharmD, MS, MHA, BCPS
Associate Director, Cancer Pharmacy Services - Ben Lopez, PharmD, MS, MHA, BCPS
Director, Enterprise Operations - Stephen Polley, PharmD, MPA, MS, BCPS
Assistant Director, Cancer Pharmacy Services - Heather Armbruster, PharmD, BCOP
Pharmacy Manager, Clinical Outpatient Services - Emily Dotson, PharmD, BCOP
Pharmacy Manager, Clinical Inpatient Services
Selected RESIDENT RESEARCH
- Evaluation of High Dose Methotrexate Clearance, Z. Arnold
- Comparison of efficacy and infectious complications of haploidentical versus matched unrelated donor allogeneic bone marrow transplants, N. Ayala-Fontanez
- Impact of Neoadjuvant Therapy on Non-Metastatic Pancreatic Cancer, C. Krall
- Predicted Fludarabine Exposure Impact on Clinical Outcomes after CAR-T therapy, N. Lamb
Benefits and Additional Requirements
Application Deadline:
January 2
We welcome applications from non-U.S. citizens who have a “green card” (permanent resident status) or a current visa valid through the entire duration of the residency program. The Ohio State University pharmacy residency programs are NOT able to sponsor visas for pharmacy residents (PGY1 or PGY2).
Start Date: July 1
Annual Salary – $56,000
Vacation Days – 10 Days
Staffing Requirement – 19 weekends per year
Completion of a Major Research Project
